ESG

A Chinese state firm claims credit for a key Vietnam power plant and vows green support, but official records and a history of pollution tell a different story.

A new partnership aims to build America's future robot security force, but raises critical questions about innovation, ethics, and surveillance.

A new partnership integrates expert rater training with eCOA tech, aiming to reduce costly data errors and accelerate development of new neurological drugs.

Utah's Odyssey House earns national acclaim from Newsweek and USA TODAY. Discover how their award-winning culture is setting a new standard for patient care.

Beztak's entire All Seasons portfolio receives top honors from U.S. News, setting a new benchmark for quality in a booming and competitive market.

Yoga giant Manduka steps into the broader fitness arena with its P/ROX mat, engineered for athletes who blend strength, cardio, and mindful movement.

Aetrex and Tradehome Shoes will provide free 3D foot scans and custom orthotics to thousands of athletes at the 2026 Special Olympics USA Games.

Tito’s Handmade Vodka becomes an official sponsor of T-Mobile Arena, launching The 1997 Lounge and a new model for corporate partnership in Las Vegas.

Facing soaring costs and armed with new laws, America's largest employers are ditching old playbooks to force transparency and value from the healthcare industry.

A company named for mining is betting big on Bali's luxury villa market. But with a tiny market cap and an unknown builder, is it a brilliant pivot or a risky gamble?

A new US-DRC partnership aims to create an ethical cobalt supply chain, challenging Chinese dominance and revitalizing American mineral processing.

The pizza giant is betting big on its new Oven-Toasted Sandwiches, using a pop-up deli and its 'Better Ingredients' promise to enter a crowded market.

Backed by Bain Capital and a veteran team, the new biotech has a de-risked pipeline from Bristol Myers Squibb aimed at transforming care for lupus and more.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.

After devastating storms, The Ritz-Carlton Oʻahu, Turtle Bay, calls for respectful tourism to help rebuild the North Shore's economy and community.

Scientists have created the first continent-wide map of bird flu's spread, explaining human cases and assessing the risk of a future pandemic.

Promising early safety data for a novel drug, KM-023, brings a potential first-ever targeted treatment for the devastating Olmsted syndrome a step closer.

A parent-led company gains a U.S. patent for a diazoxide formulation, offering new hope for managing behavioral symptoms in Prader-Willi syndrome.

Instem hires AI regulatory expert Szczepan Baran to embed submission-ready science into preclinical R&D, aiming to move beyond hype to validated results.

A new partnership between CaringKind and ADRC expands a vital, free helpline to Long Island families facing the growing challenge of Alzheimer's and dementia.